Authors: Boehm, JC Bower, MJ Gallagher, TF Kassis, S Johnson, SR Adams, JL

Citation: Jc. Boehm et al., Phenoxypyrimidine inhibitors of p38 alpha kinase: Synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-2-phenoxypyrimidin-4-yl) imidazoles, BIOORG MED, 11(9), 2001, pp. 1123-1126

Authors: Adams, JL Boehm, JC Gallagher, TF Kassis, S Webb, EF Hall, R Sorenson, M Garigipati, R Griswold, DE Lee, JC

Citation: Jl. Adams et al., Pyrimidinylimidazole inhibitors of p38: Cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity, BIOORG MED, 11(21), 2001, pp. 2867-2870

Authors: Boehm, JC Adams, JL

Citation: Jc. Boehm et Jl. Adams, New inhibitors of p38 kinase, EXPERT OP T, 10(1), 2000, pp. 25-37

Authors: Badger, AM Griswold, DE Kapadia, R Blake, S Swift, BA Hoffman, SJ Stroup, GB Webb, E Rieman, DJ Gowen, M Boehm, JC Adams, JL Lee, JC

Citation: Am. Badger et al., Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis, ARTH RHEUM, 43(1), 2000, pp. 175-183

Authors: Adams, JL Boehm, JC Kassis, S Gorycki, PD Webb, EF Hall, R Sorenson, M Lee, JC Ayrton, A Griswold, DE Gallagher, TF

Citation: Jl. Adams et al., Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreasedinhibition of hepatic cytochrome P450 enzymes, BIOORG MED, 8(22), 1998, pp. 3111-3116